Mark E. Saad

Mark E. Saad is a declared insider at 3 companies (board member); the most frequent names are Cerenome, Inc., Axsome Therapeutics, Inc. and Flyte Aviation, Inc. We count 76 filings; the first trade dates from 21 August 2006 and the latest from 8 June 2026.

Both buying and selling appear: 57 purchases worth €336k, against 4 sales worth €7.2M. On balance, insiders were net sellers of €6.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 share grants and 5 option exercises. Since January 2026: no purchases and 2 sales on the market.

The median purchase comes to €1,890. On 1 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 10 June 2026: an option exercise, in Axsome Therapeutics, Inc. The last insider purchase was made public on 19 November 2021, 1,799 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.